These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25683917)

  • 1. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE4 and mAKAPβ are nodal organizers of β2-ARs nuclear PKA signalling in cardiac myocytes.
    Bedioune I; Lefebvre F; Lechêne P; Varin A; Domergue V; Kapiloff MS; Fischmeister R; Vandecasteele G
    Cardiovasc Res; 2018 Sep; 114(11):1499-1511. PubMed ID: 29733383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
    Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
    Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy.
    Rababa'h A; Singh S; Suryavanshi SV; Altarabsheh SE; Deo SV; McConnell BK
    Int J Mol Sci; 2014 Dec; 16(1):218-29. PubMed ID: 25547489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression.
    Sheppard CL; Lee LC; Hill EV; Henderson DJ; Anthony DF; Houslay DM; Yalla KC; Cairns LS; Dunlop AJ; Baillie GS; Huston E; Houslay MD
    Cell Signal; 2014 Sep; 26(9):1958-74. PubMed ID: 24815749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylation regulates intracellular trafficking of β2 adrenergic receptor/arrestin/phosphodiesterase 4D complexes in cardiomyocytes.
    Liu R; Wang D; Shi Q; Fu Q; Hizon S; Xiang YK
    PLoS One; 2012; 7(8):e42658. PubMed ID: 22912718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
    Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
    Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.
    Abi-Gerges A; Richter W; Lefebvre F; Mateo P; Varin A; Heymes C; Samuel JL; Lugnier C; Conti M; Fischmeister R; Vandecasteele G
    Circ Res; 2009 Oct; 105(8):784-92. PubMed ID: 19745166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
    Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
    Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
    Burmeister BT; Taglieri DM; Wang L; Carnegie GK
    J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.
    De Arcangelis V; Soto D; Xiang Y
    Mol Pharmacol; 2008 Nov; 74(5):1453-62. PubMed ID: 18703669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct phosphodiesterase-4D variants integrate into protein kinase A-based signaling complexes in cardiac and vascular myocytes.
    Raymond DR; Carter RL; Ward CA; Maurice DH
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H263-71. PubMed ID: 19060129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy.
    Abi-Gerges A; Castro L; Leroy J; Domergue V; Fischmeister R; Vandecasteele G
    J Mol Cell Cardiol; 2021 Jan; 150():109-121. PubMed ID: 33184031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
    Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK
    J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases.
    Omar F; Findlay JE; Carfray G; Allcock RW; Jiang Z; Moore C; Muir AL; Lannoy M; Fertig BA; Mai D; Day JP; Bolger G; Baillie GS; Schwiebert E; Klussmann E; Pyne NJ; Ong ACM; Bowers K; Adam JM; Adams DR; Houslay MD; Henderson DJP
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13320-13329. PubMed ID: 31209056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained exposure to catecholamines affects cAMP/PKA compartmentalised signalling in adult rat ventricular myocytes.
    Fields LA; Koschinski A; Zaccolo M
    Cell Signal; 2016 Jul; 28(7):725-32. PubMed ID: 26475678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
    Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.